Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR

Immunity

Volumn 14, Issue 1, 2001, Pages 57-67

  Dykstra, Michelle L ^a   Longnecker, Richard ^b   Pierce, Susan K ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; LATENT MEMBRANE PROTEIN 2A; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0035126502     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00089-9     Document Type: Article

References (51)

1. Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: Importance depends on the nature of the antigen-antibody interaction
2. EBV persistence in memory B cells in vivo
3. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients
4. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation
5. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface
6. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
7. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice
8. Signal transduction by the B cell antigen receptor and its coreceptors
9. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
10. A role for lipid rafts in BCR signaling and antigen targeting
11. MHC class II antigen processing in B cells: Accelerated intracellular targeting of antigens
12. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line
13. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
14. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
15. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency
16. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
17. Biochemistry of B lymphocyte activation
18. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
19. Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-α and Ig-β
20. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation
21. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases
22. Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation
23. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases
24. Membrane microdomains and caveolae
25. Membrane rafts and signaling by the multichain immune recognition receptors
26. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome
27. The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region
28. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
29. Regulation of Epstein-Barr virus latency by latent membrane protein 2
30. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro
31. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
32. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction
33. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking
34. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant-negative effects on protein-tyrosine kinases
35. Cytoplasmic tail deletion converts membrane immunoglobulin to a phosphatidylinositol-linked form lacking signaling and efficient antigen internalization functions
36. Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes
37. A novel form of Epstein-Barr virus latency in normal B cells in vivo
38. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
39. T cell-dependent B cell activation
40. The B-cell antigen receptor complex: Structure and signal transduction
41. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
42. Initiation and processing of signals from the B cell antigen receptor
43. Two related Epstein-Barr virus membrane proteins are encoded by separate genes
44. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain
45. Mutations of immunoglobulin transmembrane and cytoplasmic domains: Effect on intracellular signalling and antigen presentation
46. Functional rafts in cell membranes
47. Entry of the B-cell antigen receptor and antigen into the class II peptide-loading compartment is independent of receptor cross-linking
48. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
49. Signaling through the B cell antigen receptor regulates discrete steps in the antigen processing pathway
50. B lymphocyte signaling receptors and the control of class II antigen processing
51. Capture and processing of exogenous antigens for presentation on MHC molecules